Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis

JK Peng, N Hepgul, IJ Higginson… - Palliative medicine, 2019 - journals.sagepub.com
Background: End-stage liver disease is a common cause of morbidity and mortality
worldwide, yet little is known about its symptomatology and impact on health-related quality …

Overview of complications in cirrhosis

M Premkumar, AC Anand - Journal of Clinical and Experimental …, 2022 - Elsevier
Background Cirrhosis is the outcome of chronic liver disease of any etiology due to
progressive liver injury and fibrosis. Consequently, cirrhosis leads to portal hypertension …

AASLD Practice Guidance: palliative care and symptom‐based management in decompensated cirrhosis

SS Rogal, L Hansen, A Patel, NN Ufere, M Verma… - …, 2022 - Wiley Online Library
Funding for the development of this Practice Guidance was provided by the American
Association for the Study of Liver Diseases. MV was supported by aAQ19 Patient-Centered …

Palliative care and health care utilization for patients with end-stage liver disease at the end of life

AA Patel, AM Walling, J Ricks-Oddie, FP May… - Clinical …, 2017 - Elsevier
Background & Aims There has been increased attention on ways to improve the quality of
end-of-life care for patients with end-stage liver disease; however, there have been few …

[HTML][HTML] Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment …

JE Tranmer, D Heyland, D Dudgeon, D Groll… - Journal of pain and …, 2003 - Elsevier
The objectives of this study were twofold:(1) to explore and compare the symptom
experience of seriously ill hospitalized cancer and noncancer patients near the end of life …

[HTML][HTML] Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study

B Kimbell, K Boyd, M Kendall, J Iredale, SA Murray - BMJ open, 2015 - bmjopen.bmj.com
Objective To understand the experiences and support needs of people with advanced liver
disease and those of their lay and professional carers to inform improvements in the …

The last 2 years of life: functional trajectories of frail older people

KE Covinsky, C Eng, LY Lui… - Journal of the …, 2003 - Wiley Online Library
OBJECTIVES: To characterize the functional trajectories during the last 2 years of life of
patients with progressive frailty, with and without cognitive impairment, and to assess …

Integration of palliative care in end-stage liver disease and liver transplantation

J Potosek, M Curry, M Buss… - Journal of palliative …, 2014 - liebertpub.com
Background: Patients with end-stage liver disease (ESLD) have a life-limiting illness that
causes multiple distressing symptoms and negatively affects quality of life (QOL). This …

Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective

FP Sarasin, PE Majno, JM Llovet, J Bruix, G Mentha… - Hepatology, 2001 - Elsevier
Cadaveric liver transplantation (CLT) is an excellent treatment for early hepatocellular
carcinoma (HCC). Its use, however, is limited by the shortage of grafts, with up to 30% of …

Deficits in advance care planning for patients with decompensated cirrhosis at liver transplant centers

AA Patel, GW Ryan, D Tisnado, E Chuang… - JAMA internal …, 2021 - jamanetwork.com
Importance The burden of end-of-life care for patients with cirrhosis is increasing in the US,
and most of these patients, many of whom are not candidates for liver transplant, die in …